Xbiotech Inc (XBIT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XBIT Annual Balance Sheets →
From Xbiotech Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent109.53
Cash & Short-term Investments109.00
Accounts receivable0.00
Interest Receivable, Current0.29
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.34
Total Current Assets111.16
Equipment/Property/Plant Net22.49
Other Assets, Noncurrent0.00
Total Assets133.65
Liabilities
Accounts Payable, Current AC1.11
Accrued Liabilities, Current AC2.25
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.00
Total Current Liabilities3.35
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC11.83
Other liabilities, Noncurrent0.01
Total Liabilities5.19
Stockholders' Equity
Common Stock Value277.07
Retained Earnings / Accumulated Deficit-148.61
Common Stockholder's Equity128.46
Total Stockholder's Equity128.46
Liabilities & Stockholder's Equity133.65
4 historic quarters locked

Sign in to unlock the full Xbiotech Inc balance sheet history.

About Xbiotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-005492

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.